BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 6982945)

  • 1. C1q binding and Raji immune complex assays: a comparison using defined immunoglobulin aggregates.
    Jones DB; Goulding NJ; Casey CR; Gallagher PJ
    J Immunol Methods; 1982 Sep; 53(2):201-8. PubMed ID: 6982945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of immune-complex size and antigen-antibody ratio on immune complex detection with monoclonal rheumatoid factor and C1q.
    Vanham G; Bloemmen FJ; Ceuppens JL; Stevens EA
    J Clin Lab Immunol; 1984 Oct; 15(2):63-8. PubMed ID: 6335179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding characteristics of three complement dependent assays for the detection of immune complexes in human serum.
    Krieger G; Kneba M; Bolz I; Volling P; Wessels J; Nagel GA
    J Clin Lab Immunol; 1985 Nov; 18(3):129-34. PubMed ID: 3878887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of C1q-binding IgG complexes in systemic lupus erythematosus.
    Uwatoko S; Aotsuka S; Okawa M; Egusa Y; Yokohari R; Aizawa C; Suzuki K
    Clin Immunol Immunopathol; 1984 Jan; 30(1):104-16. PubMed ID: 6421520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reactivity of low molecular weight material in cellular immune complex assays.
    Cooper KM; Moore M
    Clin Exp Immunol; 1983 May; 52(2):407-16. PubMed ID: 6602679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The IgG detected in the C1q solid-phase immune-complex assay is not always of immune-complex nature.
    Hack CE; Belmer AJ
    Clin Immunol Immunopathol; 1986 Jan; 38(1):120-8. PubMed ID: 3484437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of immune complex lattice on the C1q solid phase assay as determined with covalently cross-linked immune complexes.
    Wener MH; Mannik M
    Clin Exp Immunol; 1983 Jun; 52(3):543-50. PubMed ID: 6603296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet interactions with C1q in whole blood and in the presence of immune complexes or aggregated IgG.
    Peerschke EI; Ghebrehiwet B
    Clin Immunol Immunopathol; 1992 Apr; 63(1):45-50. PubMed ID: 1591882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating immune complex-like materials which bind to heat inactivated C1q interfere with the C1q solid phase assay for immune complexes.
    Fukuda K; Seino J; Kinoshita Y; Sudo K; Horigome I; Saito T; Furuyama T; Yoshinaga K
    Tohoku J Exp Med; 1985 Aug; 146(4):449-56. PubMed ID: 3907015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the soluble immune complexes that are detected by three different techniques.
    van der Giessen M; The TH
    Clin Immunol Immunopathol; 1986 Feb; 38(2):244-55. PubMed ID: 3484441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polyethylene glycol enhances the binding of C1q to circulating immune complexes.
    Hack CE; Eerenberg-Belmer AJ; Hannema AJ; Out TA; Aalberse RC
    J Immunol Methods; 1981; 44(2):211-21. PubMed ID: 6792284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of anti-C1q capture assay for detecting circulating immune complexes and comparison with polyethylene glycol-immunoglobulin G, C1q-binding, and Raji cell methods.
    Levinson SS; Goldman JO
    J Clin Microbiol; 1987 Aug; 25(8):1567-9. PubMed ID: 2957387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solid phase C1q microassay for the rapid detection of circulating immune complexes.
    Orozco A; Contreras CE; Sánchez P; Meilijson O; Bianco NE
    J Immunol Methods; 1983 Apr; 59(2):237-43. PubMed ID: 6341470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Critical aspects of the 125I-C1q binding assay for detecting immune complexes in tumor patients.
    Krieger G; Bause I; Kneba M; Kehl A; Nagel GA
    J Clin Lab Immunol; 1984 Jun; 14(2):87-92. PubMed ID: 6611419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-C1q column: ligand specific purification of immune complexes from human serum or plasma. Analysis of the interaction between C1q and immune complexes.
    Kilgallon W; Amlot PL; Williams BD
    Clin Exp Immunol; 1982 Jun; 48(3):705-14. PubMed ID: 6811171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The complement subcomponent C1q mediates binding of immune complexes and aggregates to endothelial cells in vitro.
    Daha MR; Miltenburg AM; Hiemstra PS; Klar-Mohamad N; Van Es LA; Van Hinsbergh VW
    Eur J Immunol; 1988 May; 18(5):783-7. PubMed ID: 3259929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-IgG type test to assay circulating immune complexes from polyethylene glycol precipitates compared with C1q binding and Raji cell tests.
    Levinson SS; Goldman J
    Clin Biochem; 1984 Dec; 17(6):341-4. PubMed ID: 6335066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating IgA immune complexes in AIDS.
    Lightfoote MM; Folks TM; Redfield R; Gold J; Sell KW
    Immunol Invest; 1985 Aug; 14(4):341-5. PubMed ID: 3877683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ability to activate complement is not required for the detection of immune complexes by the fluid-phase C1q binding assay.
    Fiocco GP; Davis JS; Burge JJ
    Arthritis Rheum; 1985 Feb; 28(2):222-5. PubMed ID: 3871617
    [No Abstract]   [Full Text] [Related]  

  • 20. In vivo reduction of circulating C1q binding immune complexes by intravenous gammaglobulin administration.
    Lin RY; Racis SP
    Int Arch Allergy Appl Immunol; 1986; 79(3):286-90. PubMed ID: 2419257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.